Organizing patient-centred anticoagulant therapy

Acta Cardiologica

Volumn 68, Issue 4, 2013, Pages 413-415

  Peter, Verhamme ^a   Hein, Heidbuchel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anticoagulation; Atrial fibrillation; Bleeding; NOAC (new oral anticoagulant); Thromboembolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; DABIGATRAN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; WARFARIN;

ARTICLE; CEREBROVASCULAR ACCIDENT; GENE EXPRESSION PROFILING; HEALTH CARE SYSTEM; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MECHANICAL HEART VALVE; PATIENT CARE; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; THROMBOEMBOLISM;

ANTICOAGULANTS; CHEMOPREVENTION; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PATIENT-CENTERED CARE; THERAPEUTIC EQUIVALENCY; THROMBOEMBOLISM;

EID: 84884145039     PISSN: 00015385     EISSN: 03737934     Source Type: Journal    
DOI: 10.2143/AC.68.4.2988895     Document Type: Article

References (8)

1. Verhamme P, Verhaeghe R. A new era for oral anticoagulation? Old and new anticoagulant drugs. Acta Cardiol 2007; 62: 189-98.
2. Camm AJ, Lip GY, De CR, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blomstrom-Lundqvist C, Colonna P, De SJ, Ernst S, Goette A, Gorenek B, Hatala R, Heidbuchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-47.
3. Heidbuchel H, Verhamme P. Dabigatran for stroke prevention in atrial fibrillation: from RE-LY to daily clinical practice. Acta Cardiol 2010; 65: 491-7.
4. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013; 15: 625-51.
5. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J 2013 Apr 26. [Epub ahead of print].
6. Van de Werf F, Brueckmann M, Connolly SJ, Friedman J, Granger CB, Hartter S, Harper R, Kappetein AP, Lehr T, Mack MJ, Noack H, Eikelboom JW. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: the randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN). Am Heart J 2012; 163: 931-7.
7. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012; 366: 9-19.
8. Berti D, Hendriks JM, Brandes A, Deaton C, Crijns HJ, Camm AJ, Hindricks G, Moons P, Heidbuchel H. A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. Eur Heart J 2013 Mar 21. [Epub ahead of print].